United States Neurodegenerative Disease Therapeutics Market Outlook 2025-2033: Navigating 9.8% CAGR with Focus on Oral Routes, North America Dominance, UCB Pharma EU Launches, and Pipeline in Monoclonal Antibodies, Immunomodulators

Neurodegenerative Disease Therapeutics Market size reached US$ 12.52 Billion in 2024 and is expected to reach US$ 28.78 Billion by 2033, growing at a CAGR of 9.8% during the forecast period 2025-2033.

According to DataM Intelligence has published a new research report on "Neurodegenerative Disease Therapeutics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

📌 Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neurodegenerative-disease-therapeutics-market?rk

➣ Recent Developments:

United States: Recent Industry Developments

✅ In August 2025, Biogen launched its next-generation Alzheimer's therapeutics targeting amyloid and tau proteins, aiming to slow disease progression in early-stage patients.

✅ In July 2025, Roche expanded its Parkinson's disease therapy portfolio with innovative monoclonal antibodies and small molecules in clinical trials across the U.S.

✅ In June 2025, Eli Lilly partnered with U.S. research institutions to advance novel neuroprotective agents for ALS and multiple sclerosis, emphasizing disease-modifying approaches.

Europe: Recent Industry Developments

✅ In July 2025, Novartis deployed gene therapy and small-molecule therapeutics for neurodegenerative diseases across EU clinical programs.

✅ In June 2025, UCB Pharma launched next-generation therapies for Alzheimer's and Parkinson's disease in European markets, focusing on symptomatic and disease-modifying effects.

✅ In May 2025, Axsome Therapeutics partnered with European research centers to accelerate clinical trials for novel CNS therapeutics, including depression and neurodegenerative indications.

☛ Neurodegenerative Disease Therapeutics Market Trends:

Technological Advancements: Innovations in gene therapy, biologics, monoclonal antibodies, and disease-modifying drugs are creating new treatment opportunities. AI and bioinformatics are also accelerating drug discovery, target validation, and clinical trial optimization.

Rising Disease Burden: Increasing aging populations worldwide and higher incidence of Alzheimer's and Parkinson's disease are major drivers for therapeutic development and market expansion.

Pipeline Expansion: A growing number of clinical trials focusing on disease-modifying therapies is fueling investment and boosting market growth prospects.

Regional Insights: North America dominates due to strong research infrastructure, regulatory support, and high healthcare spending. Asia-Pacific is emerging rapidly, supported by aging populations, government healthcare initiatives, and growing biotech R&D.

➣ Top Industry Players:

AbbVie Inc., Amneal Pharmaceuticals LLC., Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, Merck KGaA, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Ltd., Orion Corporation.

📌 Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=neurodegenerative-disease-therapeutics-market?rk

➣ Key Segments:

By Drug Class: Dopamine Agonists | Decarboxylase Inhibitors | Cholinesterase Inhibitors | Immunomodulators | Others

By Disease Type: Parkinson's Disease | Amyotrophic Lateral Sclerosis | Alzheimer's Disease | Huntington Disease | Others

By Route of Administration: Oral | Injection | Transdermal

📌 Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neurodegenerative-disease-therapeutics-market?rk

📌 Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/neurodegenerative-disease-therapeutics-market?rk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

☛ Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?rk

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.